Relapsed/Refractory Multiple Myeloma Archives

$Ongoing Studies with Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma$

Editorial Team - June 6, 2022

Editorial Team - March 27, 2023

Editorial Team - March 23, 2023

Editorial Team - March 22, 2023

Editorial Team - March 22, 2023

Editorial Team - March 21, 2023

CytoVeris and AdventHealth Central Florida Join Forces for Clinical... March 28, 2023
Study will explore how MarginASSURE, CytoVeris’ AI-powered imaging device, can help surgeons detect cancer in near real-time(PRWeb March 28, 2023)Read the full story at https://www.prweb.com/releases/cytoveris_and_adventhealth_central_florida_join_forces_for_clinical_study_to_improve_prostate_cancer_outcomes/prweb19246472.htm
CHC and Merck partner to advance more equitable health outcomes in... March 21, 2023
The collaboration aims to advance health equity and improve health outcomes for people at risk for breast and cervical cancers in underserved communities by creating a scalable model for prevention...(PRWeb March 21, 2023)Read the full story at https://www.prweb.com/releases/chc_and_merck_partner_to_advance_more_equitable_health_outcomes_in_breast_and_cervical_cancer_care_in_black_hispanic_and_other_underserved_populations/prweb19232973.htm
Unlocking the Power of Rick Simpson Oil: A Revolutionary Breakthrough... March 20, 2023
The power of Rick Simpson Oil (RSO) has been unlocked in an exciting new development. Used to treat a wide range of medical conditions and ailments, this oil is now more accessible than ever before.(PRWeb March 20, 2023)Read the full story at https://www.prweb.com/releases/unlocking_the_power_of_rick_simpson_oil_a_revolutionary_breakthrough_in_health_and_wellness/prweb19233768.htm

Tag: Relapsed/Refractory Multiple Myeloma